Kevin G. Byrnes - 11 Nov 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
11 Nov 2021
Net transactions value
-$1,031,230
Form type
4
Filing time
15 Nov 2021, 19:10:34 UTC
Previous filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise $77,359 +2,917 +36% $26.52 11,071 11 Nov 2021 Direct
transaction MED Common Stock Options Exercise $157,750 +5,000 +45% $31.55 16,071 11 Nov 2021 Direct
transaction MED Common Stock Options Exercise $138,400 +5,000 +31% $27.68 21,071 11 Nov 2021 Direct
transaction MED Common Stock Tax liability $1,404,739 -6,149 -29% $228.45 14,922 11 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Stock Options Options Exercise $0 -2,917 -100% $0.000000* 0 11 Nov 2021 Common Stock 2,917 $26.52 Direct F2
transaction MED Stock Options Options Exercise $0 -5,000 -100% $0.000000* 0 11 Nov 2021 Common Stock 5,000 $31.55 Direct F3
transaction MED Stock Options Options Exercise $0 -5,000 -100% $0.000000* 0 11 Nov 2021 Common Stock 5,000 $27.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a withholding of 6,149 shares of the Issuer's common stock to satisfy the exercise price and the tax obligation in connection with the exercise of certain stock options.
F2 These options vested in three equal annual installments beginning on February 5, 2015.
F3 These options vested in three equal annual installments beginning on February 17, 2016.
F4 These options vested in three equal annual installments beginning on February 4, 2017.